MMJ Recs

JANUARY 6, 2024

Topicals , in the form of creams, balms, or patches, target localized pain or inflammation without inducing psychoactive effects. Capsules and pills provide a familiar oral ingestion method, akin to traditional pharmaceuticals. Cannabis oils can be consumed orally, added to food, or used in various ways, offering flexibility in dosing.

Chronic Pain 52

Chronic Pain Topical Marijuana Indica 52

Cannabis Law Report

JANUARY 4, 2022

In addition, the surge in medical marijuana production owing to its increasing demand in the pharmaceutical sector is further propelling overall growth. The increasing prevalence of epilepsy and other sleep disorders is aiding the product adoption thereby, positively contributing to the segment growth. Mgc Pharmaceuticals Ltd.

Legalization 52

Legalization Supply Chain Chronic Pain Sleep 52

The Cannigma

AUGUST 29, 2021

Across the United States, the most common health condition treated with medical cannabis is chronic pain. This includes all types of pain, from neuropathic pain to fibromyalgia to joint pain from arthritis. Marijuana is safe – but there can be side effects.

Blood Pressure 87

Blood Pressure Marijuana Conditions Sleep 87

Miss Marijuana

AUGUST 7, 2020

Chronic pain. Now, while this strain is supposed to make you feel cerebral energy and pure euphoria, with the ability to give you creative thought and help you sleep at night, it is very important to remind you, the reader, that everyone reacts differently to certain strains. Lava Cake strain at a glance. Common Use. 30% Sativa.

Strains 52

Strains Indica Chronic Pain Hybrid 52

Weedistry

MARCH 9, 2019

Both CBD and THC (another cannabinoid that is found in large quantities) have incredible effects on the body that rival even the most well-recognized and powerful pharmaceuticals on the market. This is the system that helps to regulate various bodily functions like an immune response, sleep, and pain.

CBD 40

CBD Epilepsy Treatment Chronic Pain 40

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Chronic Pain. GW Pharmaceuticals, PLC. Segment Dashboard. Medical Use. Depression and Anxiety.

Recreational 95

Recreational Hemp THC Legalization 95

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

AUGUST 2, 2021

Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Miss Marijuana

MAY 17, 2020

In addition to its anti-inflammatory properties, studies indicate that medical marijuana can be used as an effective option for natural pain relief. A 2010 survey of patients suffering from chronic pain resulted in a 64% decrease in symptoms when treated with medical marijuana. Better Sleep. Natural Muscle Relaxant .

Marijuana 52

Marijuana Sleep Treatment Chronic Pain 52

Miss Marijuana

MAY 17, 2020

In addition to its anti-inflammatory properties, studies indicate that medical marijuana can be used as an effective option for natural pain relief. A 2010 survey of patients suffering from chronic pain resulted in a 64% decrease in symptoms when treated with medical marijuana. Better Sleep. Natural Muscle Relaxant .

Marijuana 52

Marijuana Sleep Treatment Chronic Pain 52

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Cancer pain. Neuropathic pain. Epilepsy or epilepsies were mentioned in 39% of articles.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

SEPTEMBER 12, 2021

There are clinical studies that show pure cannabis is more efficient than cannabis-based pharmaceuticals, and that it may produce less adverse effects. In a sense, these products resemble THC pharmaceuticals as they only contain one active ingredient from cannabis. This concentration of pure THC is then infused into the final product.

THC 98

THC Research and Development Cannabinoids CBD 98

The Cannigma

MARCH 12, 2021

Anxiety, that we have pharmaceuticals, doctors prescribe, and that is covered by insurance, and it’s also something that people use cannabis for, were using cannabis long before it was legal. But there’s a lot of space in between there. But there’s a lot of space in between there. That is a medical condition.

Legalization 128

Legalization Patients Education Dispensary 128

Green Relief

MAY 13, 2018

It is the most commonly identified cause of epilepsy among adults. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Magnesium, vitamin D, curcumin, glutathione – and melatonin to restore circadian rhythms and sleep. million Americans annually. Ancient therapies. Modern therapies.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

DECEMBER 30, 2019

Specifically, it expands the pool of patients eligible for cannabis therapy to include those with chronic pain, menstrual cramps, and epilepsy. State lawmakers passed Assembly Bill 20 , which institutes various changes to the state’s medical access program. The new law took effect on July 1, 2019.

Legislation 59

Legislation Patients Access Banking 59